Health

Health Law360 provides breaking legal news and analysis on the health care industry. Coverage includes litigation, policy developments, and corporate deals involving health care services companies such as hospitals, health insurers, physicians groups, and medical suppliers.



Sign up for a 7-day FREE trial today!



Latest News in Health

  • May 07, 2024

    GOP Reps. Want IP Enforcers To Get Tougher On Infringers

    Republican lawmakers complained at a Tuesday congressional hearing about the Biden administration's move to end the controversial Trump-era "China Initiative" aimed at curbing suspected economic espionage and questioned administration officials over how diligently they have pursued intellectual property cases on behalf of U.S. manufacturers, retailers, movie studios and vape companies.

  • May 07, 2024

    Novant CEO Vows To Improve Hospitals Facing FTC Scrutiny

    Novant Health kicked off its defense Tuesday in the Federal Trade Commission's $320 million merger challenge with testimony from its longtime CEO, who vocalized the health system's promise to reinvest in the two struggling hospitals at the center of the case.

  • May 07, 2024

    US News' Suit Over SF Ranking Probe Premature, Judge Says

    A California federal judge on Tuesday tossed without prejudice U.S. News & World Report's lawsuit challenging the San Francisco City Attorney's subpoenas seeking information about its methodology for ranking hospitals, saying the suit jumps the gun because U.S. News is not bringing a valid pre-enforcement claim.

  • May 07, 2024

    Magic Johnson's Name Used As Bait For Investors, Jury Hears

    A California man falsely told investors as the COVID-19 pandemic raged in March 2020 that he had a cure and that NBA legend Earvin "Magic" Johnson was on his company's board, a federal prosecutor told a Los Angeles federal jury Tuesday during opening statements in the man's wire fraud trial.

  • May 07, 2024

    Pharma Co. Falsely Touted Obesity Drug Results, Suit Claims

    Biopharmaceutical company Altimmune Inc. and three of its executives were hit with a proposed class action alleging they overstated the clinical trial results and prospects of its obesity drug and its ability to compete with other weight loss medications like Ozempic.

See more Health news

Health

Areas of Coverage

  • AGENCIES
  • U.S. Department of Health and Human Services
  • Centers for Medicare and Medicaid Services
  • State and international health care regulators
  • POLICY & REGULATION
  • Affordable Care Act
  • Health Insurance Portability and Accountability Act
  • Patient’s Bill of Rights
  • Stark Law
  • Consumer protection controls
  • Tax-related issues
  • Health care lobbying
  • State and international health care legislation and regulation
  • ENFORCEMENT
  • Health care fraud investigations
  • Merger reviews
  • LITIGATION
  • Medical malpractice and liability suits
  • Mass torts
  • Health care fraud disputes
  • Insurance coverage suits
  • Reimbursement disputes
  • Whistleblower and anti-corruption compliance suits
  • Antitrust suits
  • Breach of contract suits
  • Labor and employment issues
  • Shareholder disputes
  • Bankruptcy proceedings
  • TRANSACTIONS
  • Mergers, acquisitions, and joint ventures
  • Health care project finance and real estate deals
  • PROFILES
  • Personnel moves
  • Profiles of health attorneys

Readership

  • Health care lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Executives and attorneys in the health care services industry
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!